Meeting
2016 Gastrointestinal Cancers Symposium
Role of palliative resection in patients with incurable advanced gastric cancer unfit for chemotherapy.
Authors
Wataru Takagi
Division of Gastric Surgery, Shizuoka Cancer Center, Nagaizumi, Japan
Wataru Takagi , Yutaka Tanizawa , Hayato Omori , Noriyuki Nishiwaki , Keiichi Fujiya , Fumiko Hirata , Taichi Tatsubayashi , Shinsaku Honda , Makoto Hikage , Rie Makuuchi , Masanori Tokunaga , Etsuro Bando , Taiichi Kawamura , Masanori Terashima
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 114)
DOI
10.1200/jco.2016.34.4_suppl.114
Abstract #
114
Poster Bd #
L6
Abstract Disclosures
Similar Posters
Poster
2013 Gastrointestinal Cancers Symposium
Prognostic factors after R2 surgery in patients with advanced gastric cancer.
First Author: Masanori Tokunaga
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Association of disease progression pattern during third-line chemotherapy with nivolumab with poor prognosis in advanced gastric cancer: A multicenter retrospective study in Japan.
First Author: Shigenori Kadowaki
Poster
2018 ASCO Annual Meeting
An intergroup phase III trial of ramucirumab plus irinotecan in third or more line beyond progression after ramucirumab for advanced gastric cancer (RINDBeRG trial).
First Author: Daisuke Sakai
Poster
2018 Gastrointestinal Cancers Symposium
Survival impact of post-progression chemotherapy (post-Cx) in advanced gastric cancer (AGC): Systematic review and meta-analysis.
First Author: Sakura Iizumi